GT200300044A - Sal agonista del receptor beta 3-adrenergico, sus formulaciones y usos - Google Patents
Sal agonista del receptor beta 3-adrenergico, sus formulaciones y usosInfo
- Publication number
- GT200300044A GT200300044A GT200300044A GT200300044A GT200300044A GT 200300044 A GT200300044 A GT 200300044A GT 200300044 A GT200300044 A GT 200300044A GT 200300044 A GT200300044 A GT 200300044A GT 200300044 A GT200300044 A GT 200300044A
- Authority
- GT
- Guatemala
- Prior art keywords
- formulations
- beta
- salt
- adrenergic
- agonist salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36024802P | 2002-02-27 | 2002-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200300044A true GT200300044A (es) | 2003-09-22 |
Family
ID=27766205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200300044A GT200300044A (es) | 2002-02-27 | 2003-02-26 | Sal agonista del receptor beta 3-adrenergico, sus formulaciones y usos |
Country Status (8)
| Country | Link |
|---|---|
| AR (1) | AR038603A1 (fr) |
| AU (1) | AU2003248355A1 (fr) |
| GT (1) | GT200300044A (fr) |
| PA (1) | PA8567601A1 (fr) |
| PE (1) | PE20030900A1 (fr) |
| TW (1) | TW200305414A (fr) |
| UY (1) | UY27678A1 (fr) |
| WO (1) | WO2003072571A1 (fr) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9812709D0 (en) * | 1998-06-13 | 1998-08-12 | Glaxo Group Ltd | Chemical compounds |
| CA2423792A1 (fr) * | 2000-10-20 | 2002-04-25 | Pfizer Products Inc. | Ethanolamines alpha-aryle et utilisation de ces dernieres en tant qu'agonistes du recepteur adrenergique beta-3 |
-
2003
- 2003-02-17 AU AU2003248355A patent/AU2003248355A1/en not_active Abandoned
- 2003-02-17 WO PCT/IB2003/000575 patent/WO2003072571A1/fr not_active Application Discontinuation
- 2003-02-24 PE PE2003000179A patent/PE20030900A1/es not_active Application Discontinuation
- 2003-02-25 UY UY27678A patent/UY27678A1/es not_active Application Discontinuation
- 2003-02-25 AR ARP030100606A patent/AR038603A1/es not_active Application Discontinuation
- 2003-02-26 TW TW092104035A patent/TW200305414A/zh unknown
- 2003-02-26 GT GT200300044A patent/GT200300044A/es unknown
- 2003-02-26 PA PA20038567601A patent/PA8567601A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR038603A1 (es) | 2005-01-19 |
| PA8567601A1 (es) | 2003-12-10 |
| PE20030900A1 (es) | 2003-10-25 |
| UY27678A1 (es) | 2003-10-31 |
| AU2003248355A1 (en) | 2003-09-09 |
| WO2003072571A1 (fr) | 2003-09-04 |
| TW200305414A (en) | 2003-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT201000160A (es) | Derivados de aminobenzamida como agentes útiles para el control de parásitos de animales | |
| GT200500307A (es) | Compuestos quimicos | |
| GT200600114A (es) | Derivados de ciclopropanocarboxamida | |
| UY29357A1 (es) | Agonistas de pyy y sus usos | |
| CR9748A (es) | Derivados de xantina como agonistas selectivos de hm74a | |
| GT200500378A (es) | Macrolidos | |
| GT200500309A (es) | Derivados de sulfonilbencilimidazol | |
| CR7261A (es) | Derivados de diarilcicloalquilo, procedimiento para su preparacion y su utilizacion como agentes activadores del ppar | |
| GT200600453A (es) | Indoles de acilo, composiciones que contienen dichos compuestos y procedimientos de uso | |
| UY29020A1 (es) | Saliciltiazoles sustituidos con difenilamina o derivados de difenilamina, procedimientos para su preparacinn y su uso.- | |
| GT200500352A (es) | Fungicidas | |
| SV2009003349A (es) | Compuestos triciclicos, composiciones y procedimientos | |
| ECSP066625A (es) | Mezclas insecticidas sinérgicas | |
| PA8592301A1 (es) | Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
| PA8595901A1 (es) | "n-arilheterociclos sustituidos, procedimientos para su preparacion, y su empleo como medicamentos | |
| AR057222A1 (es) | Agonistas del receptor del neuropeprtido -2 | |
| CL2008001839A1 (es) | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. | |
| AR035275A1 (es) | Tieniloxipirimidinas n-heterociclil-sustituidas | |
| AR056055A1 (es) | Complejos cristalinos e hidratos de 1-cloro-4-(beta-d-glucopiranos-1-il)-2-(4-etinil-bencil)-benceno | |
| GT200600156A (es) | Compuestos heteroaromaticos acilaminobiciclicos y sus usos | |
| CR10099A (es) | Inmunoglobulinas dirigidas contra nogo | |
| AR023966A1 (es) | Una composicion farmaceutica para la prevencion y/o el tratamiento de la enfermedad de parkinson y los sintomas concomitantes de la misma, y el uso de unantagonista dual receptor de adenosina a1 a2a para preparar dicha composicion | |
| CR8068A (es) | Difluorometilobenzanilides y su uso para combatir los microorganiosmos, sus productos intermedios y el uso de estos | |
| CR11562A (es) | Bis-piridilpiridonas como antagonistas del receptor 1 de la hormona concentradora de melanina | |
| GT200600077A (es) | Imidazoles sustituidos con heterociclilamida |